Bausch Days Sales Outstanding vs Capex To Depreciation Analysis

BHC Stock

CAD 11.13 0.04 0.36%

Bausch Health financial indicator trend analysis is way more than just evaluating Bausch Health Companies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bausch Health Companies is a good investment. Please check the relationship between Bausch Health Days Sales Outstanding and its Capex To Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Days Sales Outstanding vs Capex To Depreciation

Days Sales Outstanding vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bausch Health Companies Days Sales Outstanding account and Capex To Depreciation. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Bausch Health's Days Sales Outstanding and Capex To Depreciation is -0.08. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Bausch Health Companies, assuming nothing else is changed. The correlation between historical values of Bausch Health's Days Sales Outstanding and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Bausch Health Companies are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Days Sales Outstanding i.e., Bausch Health's Days Sales Outstanding and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

-0.08

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Days Sales Outstanding

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Bausch Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Bausch Health's Selling General Administrative is very stable compared to the past year. As of the 26th of November 2024, Tax Provision is likely to grow to about 232.1 M, while Issuance Of Capital Stock is likely to drop 0.00.

	2021	2022	2023	2024 (projected)
Gross Profit	6.0B	5.8B	6.2B	6.5B
Total Revenue	8.4B	8.1B	8.8B	9.2B

Gross Profit Total Revenue

Bausch Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Inventory	Common Stock Total Equity	Short Term Investments
Total Assets		0.88	0.64	0.72	0.4	0.62	0.88	-0.2	0.33	0.31	0.99	0.47	0.31	0.86	0.74	0.93	0.54	-0.26	0.92	0.14	0.63	0.36	0.86	0.58	0.81	-0.46
Short Long Term Debt Total	0.88		0.65	0.89	0.05	0.85	1.0	-0.55	0.64	0.37	0.87	0.45	0.36	0.91	0.68	0.98	0.81	-0.38	0.98	0.47	0.73	0.4	0.66	0.82	0.85	-0.65
Other Current Liab	0.64	0.65		0.63	-0.03	0.56	0.65	-0.42	0.19	0.05	0.63	0.36	0.05	0.53	0.56	0.65	0.42	-0.25	0.65	0.27	0.43	0.32	0.4	0.38	0.61	-0.35
Total Current Liabilities	0.72	0.89	0.63		-0.19	0.87	0.87	-0.7	0.71	0.58	0.67	0.2	0.57	0.76	0.62	0.82	0.83	-0.38	0.87	0.59	0.83	0.57	0.38	0.82	0.8	-0.63
Total Stockholder Equity	0.4	0.05	-0.03	-0.19		-0.22	0.07	0.72	-0.38	-0.12	0.45	-0.03	-0.12	0.21	0.23	0.17	-0.29	0.19	0.11	-0.61	-0.15	-0.12	0.73	-0.21	0.03	0.16
Property Plant And Equipment Net	0.62	0.85	0.56	0.87	-0.22		0.85	-0.78	0.86	0.28	0.58	0.21	0.28	0.85	0.65	0.78	0.89	-0.4	0.81	0.79	0.79	0.3	0.29	0.94	0.84	-0.58
Net Debt	0.88	1.0	0.65	0.87	0.07	0.85		-0.52	0.63	0.29	0.88	0.46	0.29	0.93	0.67	0.99	0.8	-0.37	0.98	0.47	0.7	0.34	0.68	0.82	0.84	-0.63
Retained Earnings	-0.2	-0.55	-0.42	-0.7	0.72	-0.78	-0.52		-0.79	-0.32	-0.14	-0.19	-0.32	-0.41	-0.44	-0.42	-0.73	0.25	-0.47	-0.88	-0.61	-0.31	0.22	-0.74	-0.62	0.65
Accounts Payable	0.33	0.64	0.19	0.71	-0.38	0.86	0.63	-0.79		0.33	0.29	0.02	0.33	0.68	0.45	0.55	0.87	-0.33	0.59	0.87	0.69	0.24	0.07	0.94	0.63	-0.54
Cash	0.31	0.37	0.05	0.58	-0.12	0.28	0.29	-0.32	0.33		0.25	0.04	1.0	0.22	0.32	0.29	0.24	-0.18	0.34	0.07	0.51	0.64	0.1	0.28	0.37	-0.36
Non Current Assets Total	0.99	0.87	0.63	0.67	0.45	0.58	0.88	-0.14	0.29	0.25		0.46	0.25	0.85	0.71	0.92	0.51	-0.24	0.9	0.09	0.53	0.3	0.9	0.54	0.78	-0.45
Non Currrent Assets Other	0.47	0.45	0.36	0.2	-0.03	0.21	0.46	-0.19	0.02	0.04	0.46		0.04	0.4	0.23	0.53	0.19	-0.14	0.5	0.02	0.32	-0.03	0.4	0.21	0.3	-0.27
Cash And Short Term Investments	0.31	0.36	0.05	0.57	-0.12	0.28	0.29	-0.32	0.33	1.0	0.25	0.04		0.21	0.32	0.29	0.24	-0.18	0.34	0.06	0.51	0.64	0.1	0.28	0.37	-0.36
Net Receivables	0.86	0.91	0.53	0.76	0.21	0.85	0.93	-0.41	0.68	0.22	0.85	0.4	0.21		0.66	0.94	0.77	-0.41	0.93	0.48	0.71	0.17	0.71	0.85	0.8	-0.45
Common Stock Shares Outstanding	0.74	0.68	0.56	0.62	0.23	0.65	0.67	-0.44	0.45	0.32	0.71	0.23	0.32	0.66		0.66	0.5	0.07	0.66	0.32	0.53	0.31	0.52	0.56	0.92	-0.72
Non Current Liabilities Total	0.93	0.98	0.65	0.82	0.17	0.78	0.99	-0.42	0.55	0.29	0.92	0.53	0.29	0.94	0.66		0.74	-0.35	0.99	0.38	0.71	0.34	0.77	0.77	0.8	-0.57
Other Current Assets	0.54	0.81	0.42	0.83	-0.29	0.89	0.8	-0.73	0.87	0.24	0.51	0.19	0.24	0.77	0.5	0.74		-0.28	0.77	0.75	0.73	0.34	0.26	0.93	0.71	-0.55
Other Stockholder Equity	-0.26	-0.38	-0.25	-0.38	0.19	-0.4	-0.37	0.25	-0.33	-0.18	-0.24	-0.14	-0.18	-0.41	0.07	-0.35	-0.28		-0.36	-0.29	-0.34	-0.15	-0.09	-0.38	-0.2	-0.12
Total Liab	0.92	0.98	0.65	0.87	0.11	0.81	0.98	-0.47	0.59	0.34	0.9	0.5	0.34	0.93	0.66	0.99	0.77	-0.36		0.43	0.79	0.39	0.72	0.8	0.81	-0.58
Property Plant And Equipment Gross	0.14	0.47	0.27	0.59	-0.61	0.79	0.47	-0.88	0.87	0.07	0.09	0.02	0.06	0.48	0.32	0.38	0.75	-0.29	0.43		0.59	0.02	-0.2	0.78	0.51	-0.48
Total Current Assets	0.63	0.73	0.43	0.83	-0.15	0.79	0.7	-0.61	0.69	0.51	0.53	0.32	0.51	0.71	0.53	0.71	0.73	-0.34	0.79	0.59		0.47	0.32	0.8	0.66	-0.49
Short Term Debt	0.36	0.4	0.32	0.57	-0.12	0.3	0.34	-0.31	0.24	0.64	0.3	-0.03	0.64	0.17	0.31	0.34	0.34	-0.15	0.39	0.02	0.47		0.15	0.31	0.36	-0.34
Intangible Assets	0.86	0.66	0.4	0.38	0.73	0.29	0.68	0.22	0.07	0.1	0.9	0.4	0.1	0.71	0.52	0.77	0.26	-0.09	0.72	-0.2	0.32	0.15		0.32	0.5	-0.25
Inventory	0.58	0.82	0.38	0.82	-0.21	0.94	0.82	-0.74	0.94	0.28	0.54	0.21	0.28	0.85	0.56	0.77	0.93	-0.38	0.8	0.78	0.8	0.31	0.32		0.75	-0.58
Common Stock Total Equity	0.81	0.85	0.61	0.8	0.03	0.84	0.84	-0.62	0.63	0.37	0.78	0.3	0.37	0.8	0.92	0.8	0.71	-0.2	0.81	0.51	0.66	0.36	0.5	0.75		-0.71
Short Term Investments	-0.46	-0.65	-0.35	-0.63	0.16	-0.58	-0.63	0.65	-0.54	-0.36	-0.45	-0.27	-0.36	-0.45	-0.72	-0.57	-0.55	-0.12	-0.58	-0.48	-0.49	-0.34	-0.25	-0.58	-0.71

Click cells to compare fundamentals

Bausch Health Account Relationship Matchups

Bausch Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.9B	31.2B	29.2B	25.7B	27.4B	14.9B
Short Long Term Debt Total	25.9B	25.2B	22.7B	20.8B	22.4B	23.5B
Other Current Liab	2.1B	4.6B	4.8B	3.0B	1.0B	1.2B
Total Current Liabilities	6.2B	4.9B	5.2B	3.9B	4.3B	4.5B
Total Stockholder Equity	1.1B	535M	(106M)	(692M)	(1.0B)	(970.9M)
Property Plant And Equipment Net	1.5B	1.6B	1.6B	1.6B	1.7B	1.8B
Net Debt	22.7B	23.3B	22.1B	20.2B	21.4B	22.5B
Retained Earnings	(7.5B)	(8.0B)	(9.0B)	(9.2B)	(9.8B)	(9.3B)
Accounts Payable	503M	337M	407M	521M	719M	755.0M
Cash	3.2B	605M	582M	564M	947M	502.0M
Non Current Assets Total	26.9B	25.9B	23.6B	21.4B	21.8B	12.7B
Non Currrent Assets Other	411M	664M	340M	326M	307M	241.5M
Cash And Short Term Investments	3.2B	605M	582M	564M	947M	505.3M
Net Receivables	1.8B	1.6B	1.8B	1.8B	2.0B	2.1B
Common Stock Shares Outstanding	352.1M	355M	358.9M	362.9M	364.9M	246.3M
Liabilities And Stockholders Equity	33.9B	31.2B	29.2B	25.7B	27.4B	14.9B
Non Current Liabilities Total	26.5B	25.7B	24.0B	21.5B	23.1B	24.3B
Other Current Assets	779M	855M	720M	776M	1.1B	1.1B
Other Stockholder Equity	429M	454M	462M	159M	214M	203.3M
Total Liab	32.7B	30.6B	29.2B	25.4B	27.4B	28.8B
Property Plant And Equipment Gross	1.5B	1.6B	3.4B	3.5B	3.8B	4.0B
Total Current Assets	7.0B	5.3B	5.6B	4.2B	5.6B	5.9B
Accumulated Other Comprehensive Income	(2.1B)	(2.1B)	(1.9B)	(2.1B)	(1.9B)	(1.8B)
Intangible Assets	10.2B	8.4B	6.9B	5.8B	6.5B	5.8B
Inventory	1.1B	1.1B	993M	1.1B	1.5B	1.6B
Common Stock Total Equity	10.1B	10.1B	10.2B	10.2B	11.8B	6.6B
Common Stock	10.2B	10.2B	10.3B	10.4B	10.4B	7.4B
Current Deferred Revenue	2.7B	167M	2.4B	2.1B	2.4B	2.5B
Good Will	13.1B	13.0B	12.5B	11.5B	11.2B	9.0B
Other Liab	1.6B	1.5B	1.2B	967M	870.3M	826.8M
Net Tangible Assets	(22.3B)	(21.0B)	(19.5B)	(18.0B)	(20.7B)	(21.8B)
Other Assets	1.8B	2.5B	2.3B	2.3B	2.6B	1.3B
Long Term Debt	24.7B	23.9B	22.7B	20.3B	21.9B	19.1B
Short Long Term Debt	209M	228M	1.2B	432M	450M	465.3M
Property Plant Equipment	1.7B	1.8B	1.8B	1.8B	2.1B	1.7B
Long Term Debt Total	24.7B	23.9B	22.7B	20.3B	18.3B	20.1B
Capital Surpluse	429M	454M	462M	159M	143.1M	135.9M
Non Current Liabilities Other	1.1B	1.2B	855M	949M	1.0B	805.4M

Pair Trading with Bausch Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bausch Stock

0.77	RY	Royal Bank	Pair Corr
0.8	AMZN	Amazon CDR	Pair Corr
0.81	BNS	Bank of Nova Scotia Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.

The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:

How To Invest In Bausch

Details

Is Bausch Stock a good investment?

Details

What is Bausch Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bausch Days Sales Outstanding vs Capex To Depreciation Analysis

Days Sales Outstanding vs Capex To Depreciation

Days Sales Outstanding vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Days Sales Outstanding

Capex To Depreciation

Bausch Health fundamental ratios Correlations

Bausch Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bausch Health fundamental ratios Accounts

Pair Trading with Bausch Health

Moving together with Bausch Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total

Property Plant And Equipment Gross	- 0.88	Retained Earnings
Accounts Payable	- 0.79	Retained Earnings
Retained Earnings	- 0.78	Property Plant And Equipment Net
Inventory	- 0.74	Retained Earnings
Other Current Assets	- 0.73	Retained Earnings
Short Term Investments	- 0.72	Common Stock Shares Outstanding